Yahoo
OTC Markets OTCPK - Delayed Quote USD

Sinopharm Group Co. Ltd. (SHTDF)

2.0100 -0.0700 (-3.37%)
At close: October 30 at 4:00:00 PM EDT
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
571,924,484
575,167,877
584,507,930
596,569,565
552,147,550
Cost of Revenue
531,527,898
533,495,864
540,252,540
548,057,887
504,713,490
Gross Profit
40,396,586
41,672,013
44,255,390
48,511,678
47,434,060
Operating Expense
23,653,365
24,592,771
26,484,908
26,234,719
24,893,424
Operating Income
16,743,221
17,079,242
17,770,482
22,276,959
22,540,636
Net Non Operating Interest Income Expense
-1,808,251
-1,994,912
-2,328,242
-2,430,374
-3,189,992
Pretax Income
14,534,623
14,799,627
14,000,899
19,512,137
18,563,819
Tax Provision
3,857,631
3,965,193
3,577,305
4,502,309
4,218,377
Net Income Common Stockholders
7,093,181
7,155,094
7,049,683
9,053,760
8,525,655
Diluted NI Available to Com Stockholders
7,093,181
7,155,094
7,049,683
9,053,760
8,525,655
Basic EPS
2.27
2.29
2.26
2.90
2.73
Diluted EPS
2.27
2.29
2.26
2.90
2.73
Basic Average Shares
3,120,656
3,120,656
3,120,656
3,120,656
3,120,656
Diluted Average Shares
3,120,656
3,120,656
3,120,656
3,120,656
3,120,656
Total Operating Income as Reported
15,738,103
16,038,224
16,188,403
20,209,195
20,604,466
Total Expenses
555,181,263
558,088,635
566,737,448
574,292,606
529,606,914
Net Income from Continuing & Discontinued Operation
7,093,181
7,155,094
7,049,683
9,053,760
8,525,655
Normalized Income
8,269,420.0931
8,322,560.7729
9,039,638.9510
10,411,506.8016
10,029,842.9664
Interest Income
408,426
500,245
616,970
743,366
542,767
Interest Expense
2,038,420
2,300,093
2,734,038
2,956,587
3,520,326
Net Interest Income
-1,808,251
-1,994,912
-2,328,242
-2,430,374
-3,189,992
EBIT
16,573,043
17,099,720
16,734,937
22,468,724
22,084,145
EBITDA
20,624,601
21,388,775
21,468,629
26,898,972
26,249,164
Reconciled Cost of Revenue
531,527,898
533,495,864
540,252,540
548,057,887
504,713,490
Reconciled Depreciation
4,051,558
4,289,055
4,733,692
4,430,248
4,165,019
Net Income from Continuing Operation Net Minority Interest
7,093,181
7,155,094
7,049,683
9,053,760
8,525,655
Total Unusual Items Excluding Goodwill
-1,601,218
-1,594,737
-2,672,895
-1,764,912
-1,946,413
Total Unusual Items
-1,601,218
-1,594,737
-2,672,895
-1,764,912
-1,946,413
Normalized EBITDA
22,225,819
22,983,512
24,141,524
28,663,884
28,195,577
Tax Rate for Calcs
0.0003
0.0003
0.0003
0.0002
0.0002
Tax Effect of Unusual Items
-424,978.9069
-427,270.2271
-682,939.0490
-407,165.1984
-442,225.0336
12/31/2022 - 4/21/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: